PCIA
EW icon

Prime Capital Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Prime Capital Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Sell
2,834
-165
-6% -$13.8K ﹤0.01% 924
2026
Q1 		$240K Sell
2,999
-48
-2% -$3.96K ﹤0.01% 921
2025
Q4 		$260K Buy
3,047
+24
+0.8% +$1.97K ﹤0.01% 874
2025
Q3 		$235K Buy
3,023
+152
+5% +$11.9K ﹤0.01% 889
2025
Q2 		$225K Sell
2,871
-1,127
-28% -$84.1K ﹤0.01% 861
2025
Q1 		$290K Buy
+3,998
New +$286K ﹤0.01% 849
2024
Q3 		– Sell
-3,862
Closed -$357K – 939
2024
Q2 		$357K Sell
3,862
-1,720
-31% -$152K 0.01% 672
2024
Q1 		$533K Buy
5,582
+229
+4% +$19.2K 0.01% 606
2023
Q4 		$408K Buy
5,353
+1,331
+33% +$92.6K 0.01% 631
2023
Q3 		$279K Buy
4,022
+84
+2% +$6.75K 0.01% 608
2023
Q2 		$371K Buy
+3,938
New +$342K 0.01% 543
2023
Q1 		– Sell
-3,381
Closed -$252K – 584
2022
Q4 		$252K Buy
+3,381
New +$261K 0.01% 450
2018
Q4 		– Sell
-2,115
Closed -$123K – 374
2018
Q3 		$123K Buy
2,115
+1,803
+578% +$88.2K 0.04% 148
2018
Q2 		$15K Buy
+312
New +$14.6K 0.01% 256

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prime Capital Investment Advisors's EW Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Edwards Lifesciences (EW) stake by 5.5% in Q2 2026, selling an estimated $13.8K and leaving 2,834 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Prime Capital Investment Advisors first reported a position in EW in Q2 2018 and has held it in 14 quarters since. The position peaked at $533K in Q1 2024. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Prime Capital Investment Advisors held 2,834 shares of Edwards Lifesciences worth $256K as of Q2 2026.
  • Prime Capital Investment Advisors sold 165 Edwards Lifesciences shares in Q2 2026, an estimated $13.8K.
  • Edwards Lifesciences made up ﹤0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #924 holding.
  • Prime Capital Investment Advisors first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 14 quarters since.
  • Prime Capital Investment Advisors's Edwards Lifesciences position peaked at $533K in Q1 2024.
  • 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.